Special Issue "Precision Medicine: Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy"
Deadline for manuscript submissions: closed (30 June 2020) | Viewed by 25071
A printed edition of this Special Issue is available here.
Interests: drug metabolism and CYP450s; pharmacogenomics; drug-induced Long Qt Syndrome; clinical decision support systems; risk stratification and drug-related adverse events
Precision medicine proposes that the current knowledge and technologies be used to tailor medical decisions, treatments, practices or products to individual patients. This domain has evolved significantly from the studies of Pythagoras with fava beans 510 BC, to Snyder’s study on phenothiocarbamide in 1932, to Vogel who coined the term “pharmacogenetics” and the first textbook on pharmacogenetics by Kalow in 1962, to the first approval of a pharmacogenetic test by the FDA in 2005, and finally, to researches conducted since the Precision Medicine Initiative launched at the 2015 State of The Union address by President Obama. We propose to assemble a series of original publications on “Applied Concepts of Pharmacogenomics in Patients with Multiple Diseases and Polypharmacy”. This collection of articles should become a source of information for healthcare providers eager to apply in their clinical activities new concepts of Precision Medicine.
Prof. Jacques Turgeon
Prof. Veronique Michaud
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Precision medicine
- Anticoagulant drugs
- Antiplatelet agents
- Drug metabolism
- Drug transporters
- Cardiovascular drugs